The Belgian biotech company Spica Therapeutics, specialist for Macrophages biology, appointed Jeff Abbey as new Chief Executive Officer in October.
ADVERTISEMENT
ADVERTISEMENT
Log in here to read the desired article.
ADVERTISEMENT
The Belgian biotech company Spica Therapeutics, specialist for Macrophages biology, appointed Jeff Abbey as new Chief Executive Officer in October.

